Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association

scientific article published on 24 April 2013

Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/HHF.0B013E318291329A
P932PMC publication ID3908895
P698PubMed publication ID23616602

P50authorIleana L PiñaQ114291623
Paul A HeidenreichQ37840942
Gregg C. FonarowQ38543909
David A. BluemkeQ39818611
Javed ButlerQ63107356
Olga A KhavjouQ87070675
Council on Clinical CardiologyQ98732021
P2093author name stringLarry A Allen
Graham Nichol
Thomas M Maddox
Council on Cardiovascular Radiology and Intervention
Nancy M Albert
Marvin A Konstam
John S Ikonomidis
Michael Pham
Council on Epidemiology and Prevention
Justin G Trogdon
American Heart Association Advocacy Coordinating Committee
Stroke Council
Council on Arteriosclerosis, Thrombosis and Vascular Biology
P2860cites workPalliative Care in the Treatment of Advanced Heart FailureQ22306344
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]Q22306349
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>Q28204197
Improved treatment of hospitalized coronary artery disease patients with the get with the guidelines programQ28221152
2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in AdultsQ28239484
Heart disease and stroke statistics--2011 update: a report from the American Heart AssociationQ29547236
Heart disease and stroke statistics--2012 update: a report from the American Heart AssociationQ29547909
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesQ29619614
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart AssociationQ30080021
A reengineered hospital discharge program to decrease rehospitalization: a randomized trialQ30228286
Cardiac performance measure compliance in outpatients: the American College of Cardiology and National Cardiovascular Data Registry's PINNACLE (Practice Innovation And Clinical Excellence) programQ33629846
Long-term trends in Medicare payments in the last year of lifeQ33725839
Interventions to reduce 30-day rehospitalization: a systematic reviewQ34050414
The economic costs of illness: a replication and updateQ34313474
The care transitions intervention: results of a randomized controlled trialQ34568833
Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyondQ34615977
Contemporary treatment of heart failure: is there adequate evidence to support a unique strategy for African-Americans? Con positionQ34738535
Consensus statement: Palliative and supportive care in advanced heart failureQ35800974
Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart AssociationQ35806046
Heart failure clinics and outpatient management: review of the evidence and call for quality assuranceQ35879710
Clinical epidemiology of heart failureQ35954269
Incidence and epidemiology of heart failureQ36287940
Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of CardiologyQ36811824
Use of econometric models to estimate expenditure sharesQ36839690
National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008Q36944032
Acculturation and outcomes among patients with heart failureQ37205787
Hospice use among patients with heart failureQ37525157
Palliative care in congestive heart failureQ37560224
Guided care and the cost of complex healthcare: a preliminary report.Q37577888
Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007.Q37799463
Potential impact of optimal implementation of evidence-based heart failure therapies on mortalityQ37884919
Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).Q38371676
Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trialQ38375039
Associations between outpatient heart failure process-of-care measures and mortalityQ38492646
A randomized trial of a telephone care-management strategyQ39835102
The care transitions intervention: translating from efficacy to effectivenessQ39992432
Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research IntQ40106164
The Seattle Heart Failure Model: prediction of survival in heart failureQ40343385
Evaluation of the transitional care model in chronic heart failure.Q42783441
Discharge education improves clinical outcomes in patients with chronic heart failureQ43589881
Hospital performance recognition with the Get With The Guidelines Program and mortality for acute myocardial infarction and heart failureQ44402061
Symptom recognition in elders with heart failure.Q45943079
The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report--2010.Q45945360
Insulin resistance and risk of congestive heart failureQ46609295
Effectiveness and cost of a transitional care program for heart failure: a prospective study with concurrent controlsQ46839283
Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction: a study across therapeutic erasQ47298864
Race, quality of care, and outcomes of elderly patients hospitalized with heart failureQ47898142
The Medical Expenditure Panel Survey: a national health information resource.Q50107889
A national study of the quantity and cost of informal caregiving for the elderly with stroke.Q50697432
ACCF/AHA/HFSA 2011 survey results: current staffing profile of heart failure programs, including programs that perform heart transplant and mechanical circulatory support device implantation: a report of the ACCF Heart Failure and Transplant CommittQ51042627
Modifiable risk factors for incident heart failure in the coronary artery surgery study.Q51596688
Estimating log models: to transform or not to transform?Q52058429
AHA/ACCF 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop PerfoQ57072822
Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006Q57243464
Social Support and Self-care in Heart FailureQ57315242
Compliance with non-pharmacological recommendations and outcome in heart failure patientsQ57315246
Care and Outcomes of Hispanic Patients Admitted With Heart Failure With Preserved or Reduced Ejection FractionQ57630429
Association of race/ethnicity with clinical risk factors, quality of care, and acute outcomes in patients hospitalized with heart failureQ57630486
Implementing American Heart Association Pediatric and Adult Nutrition GuidelinesQ58080508
ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 GuQ58975447
Advanced Heart Failure and Transplant Cardiology: A Subspecialty Is BornQ59192104
ACC/AHA Clinical Performance Measures for Adults With Chronic Heart FailureQ62023646
Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunctionQ73856257
Clinical definition and epidemiology of advanced heart failureQ74660324
Transitional care of older adults hospitalized with heart failure: a randomized, controlled trialQ79932365
Posthospital medication discrepancies: prevalence and contributing factorsQ81203289
Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trialQ81636956
Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990-1994Q82484608
ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical AsQ84352844
American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular careQ94435023
ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician ConsortQ95479891
P433issue3
P921main subjectUnited States of AmericaQ30
heart failureQ181754
P304page(s)606-619
P577publication date2013-04-24
P1433published inCirculation: Heart FailureQ2865806
P1476titleForecasting the impact of heart failure in the United States: a policy statement from the American Heart Association
P478volume6

Reverse relations

cites work (P2860)
Q8836065630-Day Episode Payments and Heart Failure Outcomes Among Medicare Beneficiaries
Q38620927A Central Role for Monocyte-Platelet Interactions in Heart Failure
Q89891714A Comparison of Hospitalized Patients With Heart Failure and Cancer Referred to Palliative Care
Q47105229A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function
Q90716625A Network Pharmacology Approach to Explore the Mechanisms of Qishen Granules in Heart Failure
Q90224720A Randomized Trial of Video-based Education in Patients With Heart Failure: The Congestive Heart Failure Outreach Program of Education (COPE)
Q36961651A Remote Medication Monitoring System for Chronic Heart Failure Patients to Reduce Readmissions: A Two-Arm Randomized Pilot Study.
Q39336176A Review of Prognostic Tools in Heart Failure.
Q91505253A Roadmap for Value-Based Payment Models Among Patients With Cirrhosis
Q36296879A Robust e-Epidemiology Tool in Phenotyping Heart Failure with Differentiation for Preserved and Reduced Ejection Fraction: the Electronic Medical Records and Genomics (eMERGE) Network
Q89293222A Systematic Review of Cardiovascular Disease in Sexual Minorities
Q38626987A Systematic Review of mHealth-Based Heart Failure Interventions
Q92512572A Systems-Based Analysis of the CardioMEMS HF Sensor for Chronic Heart Failure Management
Q35672064A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010.
Q38781009A functional variant of the neuropeptide S receptor-1 gene modulates clinical outcomes and healthcare utilization in patients with systolic heart failure: results from the Interdisciplinary Network Heart Failure (INH) Study
Q47564964A mixed methods study of symptom perception in patients with chronic heart failure
Q55075632A mobile system for the improvement of heart failure management: Evaluation of a prototype.
Q91433760A mouse model of heart failure exhibiting pulmonary edema and pleural effusion: Useful for testing new drugs
Q37675569A new twist on an old idea: a two-dimensional speckle tracking assessment of cyclosporine as a therapeutic alternative for heart failure with preserved ejection fraction
Q37730741A novel approach for measuring residential socioeconomic factors associated with cardiovascular and metabolic health
Q92894318A novel noninvasive method for remote heart failure monitoring: the EuleriAn video Magnification apPLications In heart Failure studY (AMPLIFY)
Q39890028A prospective, observational study to explore health disparities in patients with heart failure-ethnicity and financial status
Q40929884A randomized study of remote monitoring and fluid monitoring for the management of patients with implanted cardiac arrhythmia devices
Q28297096AAV-mediated gene therapy for heart failure: enhancing contractility and calcium handling
Q89071693Ablation for Atrial Fibrillation in Heart Failure with Reduced Ejection Fraction
Q57128494Ablation of a Single N-Glycosylation Site in Human FSTL 1 Induces Cardiomyocyte Proliferation and Cardiac Regeneration
Q52656155Accelerometer-Measured Daily Activity Levels and Related Factors in Patients With Heart Failure.
Q50231051Acetylation of VGLL4 Regulates Hippo-YAP Signaling and Postnatal Cardiac Growth.
Q41104203Activation of the Amino Acid Response Pathway Blunts the Effects of Cardiac Stress
Q35139964Acute decompensated heart failure update
Q37408637Acute heart failure with preserved ejection fraction: unique patient characteristics and targets for therapy
Q57911301Acute heart failure: lessons learned, roads ahead
Q38674901Acute mechanical circulatory support for cardiogenic shock: the "door to support" time
Q48387891Addressing the conundrum of multimorbidity in heart failure: Do we need a more strategic approach to improve health outcomes?
Q40967753Adherence to a Mediterranean diet is associated with reduced risk of heart failure in men.
Q64959122Adiponectin is valuable in the diagnosis of acute heart failure with renal insufficiency.
Q38665321Adverse Remodeling and Reverse Remodeling After Myocardial Infarction
Q46136583Aerobic fitness, muscular strength and obesity in relation to risk of heart failure.
Q44143731Almanac 2013: heart failure
Q89071699Ambulatory Intra Aortic Balloon Pump in Advanced Heart Failure
Q38219915Amino acids and derivatives, a new treatment of chronic heart failure?
Q47724995An Intervention to Improve Physical Function and Caregiver Perceptions in Family Caregivers of Persons With Heart Failure
Q64245345An update on the CardioMEMS pulmonary artery pressure sensor
Q90673843Anabolism to Catabolism: Serologic Clues to Nutritional Status in Heart Failure
Q89307259Anemia in heart failure - from guidelines to controversies and challenges
Q38982213Angiotensin-Neprilysin Inhibition as a Paradigm for All?
Q64948831Assessing Knowledge Regarding Managing Congestive Health Failure Symptoms: Differences in Patient and Professional Scores.
Q27012929Assessing the Quality and Comparative Effectiveness of Team-Based Care for Heart Failure: Who, What, Where, When, and How
Q52985344Assessment of cardiac sympathetic innervation with (123)I-mIBG SPECT comes to life: need for standardization!
Q92018520Association Between Spending and Survival of Chronic Heart Failure Across Veterans Affairs Medical Centers
Q39689820Association between cardiac, renal, and hepatic biomarkers and outcomes in patients with acute heart failure
Q90219054Association between long-term adherence to class-I recommended medications and risk for potentially preventable heart failure hospitalizations among younger adults
Q97557924Association of Adherence to Weight Telemonitoring With Health Care Use and Death: A Secondary Analysis of a Randomized Clinical Trial
Q37240444Association of Age at Menopause With Incident Heart Failure: A Prospective Cohort Study and Meta-Analysis
Q40249444Association of Holter-Derived Heart Rate Variability Parameters With the Development of Congestive Heart Failure in the Cardiovascular Health Study
Q89266872Association of the Affordable Care Act's Medicaid Expansion With Care Quality and Outcomes for Low-Income Patients Hospitalized With Heart Failure
Q90332618Associations Between Long-Term Fine Particulate Matter Exposure and Mortality in Heart Failure Patients
Q56975424Atorvastatin, but not pravastatin, inhibits cardiac Akt/mTOR signaling and disturbs mitochondrial ultrastructure in cardiac myocytes
Q39008820Atrial fibrillation and cognitive function in patients with heart failure: a systematic review and meta-analysis.
Q39888565Augmenting Surgery via Multi-scale Modeling and Translational Systems Biology in the Era of Precision Medicine: A Multidisciplinary Perspective
Q47655019Automating Quality Measures for Heart Failure Using Natural Language Processing: A Descriptive Study in the Department of Veterans Affairs
Q36165288Autonomic Regulation Therapy in Heart Failure
Q90249372Baduanjin exercise for patients with ischemic heart failure on phase-II cardiac rehabilitation (BEAR trial): study protocol for a prospective randomized controlled trial
Q37090685Barriers to Adoption of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure: A Mixed-Methods Study
Q52709074Beneficial effects of adaptive servo-ventilation therapy on readmission and medical costs in patients with chronic heart failure.
Q94337976Beta‐blockers for heart failure
Q36351720Biological significance of miR-126 expression in atrial fibrillation and heart failure
Q33870611Biomaterial-Free Three-Dimensional Bioprinting of Cardiac Tissue using Human Induced Pluripotent Stem Cell Derived Cardiomyocytes
Q40379760Blood pressure changes in patients with chronic heart failure undergoing slow breathing training
Q52682504Bone Morphogenetic Protein 9 Reduces Cardiac Fibrosis and Improves Cardiac Function in Heart Failure.
Q40935755Broadcasting Not Properly: Using B-type Natriuretic Peptide Interval Likelihood Ratios and the Results of Other Emergency Department Tests to Diagnose Acute Heart Failure in Dyspneic Patients
Q38979269Burden and Timing of Hospitalizations in Heart Failure: A Community Study
Q98241459Burden of Cirrhosis on Patients and Caregivers
Q36784206Burden of Systolic and Diastolic Left Ventricular Dysfunction Among Hispanics in the United States: Insights From the Echocardiographic Study of Latinos
Q47701044Can Mindfulness Training Improve Medication Adherence? Integrative Review of the Current Evidence and Proposed Conceptual Model
Q31159585Can Vaccinations Improve Heart Failure Outcomes?: Contemporary Data and Future Directions
Q92155818Cardiac Inotropic Effect of Long-Term Administration of Oral Thymoquinone
Q38939243Cardiac Myosin Activators in Systolic Heart Failure: More Friend than Foe?
Q93055900Cardiac Myosin Binding Protein-C Phosphorylation Mitigates Age-Related Cardiac Dysfunction: Hope for Better Aging?
Q88711515Cardiac Resynchronisation Therapy and Heart Failure: Persepctive from 5P Medicine
Q37416037Cardiac STAT3 Deficiency Impairs Contractility and Metabolic Homeostasis in Hypertension
Q62471522Cardiac ScoreCard: A diagnostic multivariate index assay system for predicting a spectrum of cardiovascular disease
Q37371212Cardiac contractility modulation: a novel approach for the treatment of heart failure
Q55025652Cardiac myosin activators for heart failure therapy: focus on omecamtiv mecarbil.
Q41598736Cardiac troponin and outcome in decompensated heart failure with preserved ejection fraction
Q47265220Cardiac-specific ablation of the E3 ubiquitin ligase Mdm2 leads to oxidative stress, broad mitochondrial deficiency and early death
Q64107766CardioMems® device implantation reduces repeat hospitalizations in heart failure patients: A single center experience
Q39258979Cardiomyocyte Ca2+ homeostasis as a therapeutic target in heart failure with reduced and preserved ejection fraction.
Q64229554Cardiomyocyte SMAD4-Dependent TGF-β Signaling is Essential to Maintain Adult Heart Homeostasis
Q61659889Cardionephrology: Proposal for a Futuristic Educational Approach to a Contemporary Need
Q91698768Cardiorespiratory fitness, body mass index and heart failure incidence
Q40365259Cardiovascular Disease Risk Among Young Urban Women
Q50098369Cardiovascular Medicine Amid Evolving Health Policy: Time to Train a Generation of Policy Leaders.
Q33912880Cardiovascular magnetic resonance in an adult human population: serial observations from the multi-ethnic study of atherosclerosis.
Q64906097Cardiovascular risk prediction in the elderly.
Q42378575Cardiovascular risk reduction in African Americans: Current concepts and controversies
Q35629821Care in the last year of life for community patients with heart failure
Q37305320Caregiver Contribution to Heart Failure Self-Care (CACHS)
Q55668722Caregiver Well-being and Patient Outcomes in Heart Failure: A Meta-analysis.
Q38781161Caregiver determinants of patient clinical event risk in heart failure
Q47599898Caregivers' perceptions of illness severity and end of life service utilization in advanced heart failure.
Q87590979Carvedilol protects the infarcted heart by upregulating miR-133: first evidence that disease state affects β-adrenergic arrestin-biased signaling?
Q47639049Cellular Therapeutics for Heart Failure: Focus on Mesenchymal Stem Cells.
Q30357486Challenges and opportunities for translating medical microdevices: insights from the programmable bio-nano-chip.
Q28085736Challenges in acute heart failure clinical management: optimizing care despite incomplete evidence and imperfect drugs
Q57796885Changes in pulmonary artery pressure before and after left ventricular assist device implantation in patients utilizing remote haemodynamic monitoring
Q43145398Chinese innovation in cardiovascular drug discovery
Q33616957Chocolate Consumption and Risk of Heart Failure: A Meta-Analysis of Prospective Studies
Q30359729Chronic subcutaneous brain natriuretic peptide therapy in asymptomatic systolic heart failure.
Q88129484Circular noncoding RNAs as potential therapies and circulating biomarkers for cardiovascular diseases
Q91638459Clinical characteristics of heart failure associated with functional dependence at admission in hospitalized elderly
Q57176446Clinical correlates and heritability of cardiac mechanics: The HyperGEN study
Q92858769Clinical efficacy, safety and tolerability of aliskiren monotherapy: a protocol for an umbrella review
Q55282032Clinical implications of organ congestion in heart failure patients as assessed by ultrasonography.
Q38588158Clinical management of patients with acute heart failure
Q91604539Clinical outcomes and mortality in old and very old patients undergoing cardiac resynchronization therapy
Q40485446Clinical presentation and outcome by age categories in acute heart failure: results from an international observational cohort
Q38999245Coagulation Abnormalities in Heart Failure: Pathophysiology and Therapeutic Implications
Q49022015Combination of angiotensin II and l-NG-nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure.
Q39262364Combined Post- and Precapillary Pulmonary Hypertension in Patients With Heart Failure
Q40000430Combining angiotensin II receptor 1 antagonism and neprilysin inhibition for the treatment of heart failure
Q38717849Comorbidities in Heart Failure: Are There Gender Differences?
Q38666884Comorbidity of atrial fibrillation and heart failure
Q36021840Comparative effects of urocortins and stresscopin on cardiac myocyte contractility
Q89912395Comparing inpatient costs of heart failure admissions for patients with reduced and preserved ejection fraction with or without type 2 diabetes
Q99707623Comparison of learning needs priorities between healthcare providers and patients with heart failure
Q38717846Complex Care Options for Patients With Advanced Heart Failure Approaching End of Life
Q34635174Congestive heart failure adherence redesign trial: a pilot study
Q26778120Considerations for initial therapy in the treatment of acute heart failure
Q37041145Contemporary strategies in the diagnosis and management of heart failure
Q41031667Corlanor (Ivabradine), First HCN Channel Blocker, FDA Approved for the Treatment of Patients with Heart Failure
Q52604700Correcting Calcium Dysregulation in Chronic Heart Failure Using SERCA2a Gene Therapy.
Q37723855Cost of heart failure management in Turkey: results of a Delphi Panel
Q35357554Cost of informal caregiving for patients with heart failure
Q36853325Cost-Effectiveness of Implantable Pulmonary Artery Pressure Monitoring in Chronic Heart Failure
Q36956750Cost-Effectiveness of Ivabradine for Heart Failure in the United States
Q38921111Cost-Effectiveness of Remote Cardiac Monitoring With the CardioMEMS Heart Failure System.
Q88621944Cost-effectiveness of B-type natriuretic peptide-guided care in patients with heart failure: a systematic review
Q101238372Cost-effectiveness of adding dapagliflozin to standard treatment for heart failure with reduced ejection fraction patients in China
Q37344039Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece
Q38612606Current Approach to Decongestive Therapy in Acute Heart Failure
Q55182135Current Perspectives on Systemic Hypertension in Heart Failure with Preserved Ejection Fraction.
Q89350823Current State of Pediatric Heart Failure
Q36139763Current and projected burden of heart failure in the Australian adult population: a substantive but still ill-defined major health issue.
Q50332202Current indications for transplantation: stratification of severe heart failure and shared decision-making.
Q31172420DCDS: A Real-time Data Capture and Personalized Decision Support System for Heart Failure Patients in Skilled Nursing Facilities
Q49794362Defining the molecular signatures of human right heart failure.
Q38827917Defining the role of ultrafiltration therapy in acute heart failure: a systematic review and meta-analysis
Q35864658Dementia severity and the longitudinal costs of informal care in the Cache County population
Q38969053Depression increases the risk of mortality in patients with heart failure: A meta-analysis
Q37742294Design and Usability of a Heart Failure mHealth System: A Pilot Study
Q63284032Design and rationale of the B-lines lung ultrasound guided emergency department management of acute heart failure (BLUSHED-AHF) pilot trial
Q46746456Design of a bilevel clinical trial targeting adherence in heart failure patients and their providers: The Congestive Heart Failure Adherence Redesign Trial (CHART).
Q47148472Designing and Testing an End-of-Life Discussion Intervention for African American Patients With Heart Failure and Their Families
Q34162294Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries
Q37220202Detection and prognostic value of pulmonary congestion by lung ultrasound in ambulatory heart failure patients
Q64109356Detection of Congestive Heart Failure Based on LSTM-Based Deep Network via Short-Term RR Intervals
Q36304296Determinants of Heart Failure Self-Care Maintenance and Management in Patients and Caregivers: A Dyadic Analysis.
Q52579369Determining 30-day readmission risk for heart failure patients: the Readmission After Heart Failure scale.
Q38532870Development of a collaborative transitions-of-care program for heart failure patients
Q28080130Diagnosing and managing acute heart failure in the emergency department
Q64251843Diagnosing heart failure in centenarians
Q58552891Diagnostic potential of circulating LncRNAs in human cardiovascular disease: a meta-analysis
Q51769291Digoxin Benefit Varies by Risk of Heart Failure Hospitalization: Applying the Tufts MC HF Risk Model.
Q35019683Dilemmas in end-stage heart failure
Q34514036Dimensionality and reliability of the self-care of heart failure index scales: further evidence from confirmatory factor analysis.
Q55421109Direct Cardiac Reprogramming: Progress and Promise.
Q38766202Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure
Q34357452Diuretic use in heart failure and outcomes
Q41385955Do anabolic nutritional supplements stimulate human growth hormone secretion in elderly women with heart failure?
Q35179984Does B-type natriuretic peptide-guided therapy improve outcomes in patients with chronic heart failure? A systematic review and meta-analysis of randomized controlled trials
Q42698007Does an intervention designed to improve self-management, social support, and awareness of palliative care address needs of persons with heart failure, family caregivers, and clinicians?
Q64965703Does the heart transplant have a future?
Q47784475Early warning systems for the management of chronic heart failure: a systematic literature review of cost-effectiveness models
Q55346961Echo and heart failure: when do people need an echo, and when do they need natriuretic peptides?
Q33704000Economic burden of hospitalizations of Medicare beneficiaries with heart failure
Q51738672Editorial: Transitional Care Clinics to Reduce 30-day Readmissions in Heart Failure Patients.
Q60301597Effect of early physician follow-up on mortality and subsequent hospital admissions after emergency care for heart failure: a retrospective cohort study
Q92243191Effects of Bariatric Surgery on Cardiovascular Disease: A Concise Update of Recent Advances
Q33722076Effects of Transendocardial Stem Cell Injection on Ventricular Proarrhythmia in Patients with Ischemic Cardiomyopathy: Results from the POSEIDON and TAC-HFT Trials
Q36968934Effects of Vitamin D on Cardiac Function in Patients With Chronic HF: The VINDICATE Study
Q40388134Efficacy and Safety of Intravenous Chlorothiazide versus Oral Metolazone in Patients with Acute Decompensated Heart Failure and Loop Diuretic Resistance.
Q48044954Efficacy and safety of saxagliptin compared with acarbose in Chinese patients with type 2 diabetes mellitus uncontrolled on metformin monotherapy: Results of a Phase IV open-label randomized controlled study (the SMART study).
Q93106869Efficacy of Vitamin D on Chronic Heart Failure Among Adults
Q48504109Efficacy of intramyocardial injection of Algisyl-LVR for the treatment of ischemic heart failure in swine.
Q47658430Efficient selective screening for heart failure in elderly men and women from the community: A diagnostic individual participant data meta-analysis
Q37721784Egg Consumption and Incidence of Heart Failure: A Meta-Analysis of Prospective Cohort Studies
Q38678700Electrocardiographic Predictors of Heart Failure With Reduced Versus Preserved Ejection Fraction: The Multi-Ethnic Study of Atherosclerosis
Q41746137Electrocardiographic Versus Echocardiographic Left Ventricular Hypertrophy in Prediction of Congestive Heart Failure in the Elderly.
Q37391005Electronically monitored medication adherence predicts hospitalization in heart failure patients
Q38694200Emerging Therapies for Acute and Chronic Heart Failure: Hope or Hype?
Q47102600Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Q37237663Entresto (Sacubitril/Valsartan): First-in-Class Angiotensin Receptor Neprilysin Inhibitor FDA Approved for Heart Failure
Q36257575Entresto (Sacubitril/Valsartan): First-in-Class Angiotensin Receptor Neprilysin Inhibitor FDA Approved for Patients with Heart Failure
Q36905978Epidemiology and aetiology of heart failure
Q36606191Epidemiology and cost of heart failure in children.
Q37318509Epidemiology of Heart Failure in Korea: Present and Future
Q38580530Epidemiology of Right Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction
Q30234501Epidemiology of heart failure with preserved ejection fraction
Q33563221Epidemiology, pathophysiology, and prognosis of heart failure in the elderly
Q93129318Epigenetic therapies in heart failure
Q88453278Epigenetics of Aberrant Cardiac Wound Healing
Q38408408Epigenetics of the failing heart
Q88489317Essential Elements of Early Post Discharge Care of Patients with Heart Failure
Q38789122Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): A multidisciplinary position statement.
Q90667730Estradiol Treatment Initiated Early After Ovariectomy Regulates Myocardial Gene Expression and Inhibits Diastolic Dysfunction in Female Cynomolgus Monkeys: Potential Roles for Calcium Homeostasis and Extracellular Matrix Remodeling
Q38905198European Society of Cardiology - Acute Cardiovascular Care Association position paper on safe discharge of acute heart failure patients from the emergency department
Q92658815Evaluating risk prediction models for adults with heart failure: A systematic literature review
Q39651924Evaluation of Mortality and Readmissions following Hospitalization with Heart Failure
Q35778912Evaluation of the Methods and Management of Acute Coronary Events (EMMACE)-3: protocol for a longitudinal study
Q35139977Evolution of biomarker guided therapy for heart failure: current concepts and trial evidence.
Q88586628Examining Characteristics of Hospitalizations in Heart Failure Patients: Results from the 2009 All-payer Data
Q37143327Exercise Intolerance In Heart Failure With Preserved Ejection Fraction
Q64233594Exercise Training and Heart Failure: A Review of the Literature
Q100954812Experimental model of congestive heart failure induced by transverse aortic constriction in BALB/c mice
Q89495782Expression of microRNA-214 and galectin-3 in peripheral blood of patients with chronic heart failure and its clinical significance
Q90157368Extending Behavioral Medicine to Heart Failure With Preserved Ejection Fraction
Q35046698Factors associated with variations in hospital expenditures for acute heart failure in the United States
Q38761727Family caregiving for persons with heart failure at the intersection of heart failure and palliative care: a state-of-the-science review.
Q44605331Feasibility of including patients with migration background in a structured heart failure management programme: A prospective case-control study exemplarily on Turkish migrants
Q33880939Fluid overload as a major target in management of cardiorenal syndrome: Implications for the practice of peritoneal dialysis
Q64938227Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan.
Q59806747From bedside to bench and back again: translational studies of mechanical unloading of the left ventricle to promote recovery after acute myocardial infarction
Q38687232Future Prospects for the Total Artificial Heart
Q33740534Future declines of coronary heart disease mortality in England and Wales could counter the burden of population ageing.
Q54088960G protein-coupled estrogen receptor (GPER) deficiency induces cardiac remodeling through oxidative stress.
Q42359693GPER is required for the age-dependent upregulation of the myocardial endothelin system
Q38400860Gastric Bypass Surgery Produces a Durable Reduction in Cardiovascular Disease Risk Factors and Reduces the Long-Term Risks of Congestive Heart Failure
Q52628857Gastrointestinal Hemorrhage in Left Ventricular Assist Device Patients: Red Scare or Pressure from the Right?
Q38843833Gender Differences in the Risk of Adverse Outcomes in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction
Q91270618Gender differences in Egyptian patients hospitalized with heart failure: insights from the European Society of Cardiology Heart Failure Long-Term Registry
Q90663940Genetics of dilated cardiomyopathy: practical implications for heart failure management
Q57095663Global Public Health Burden of Heart Failure
Q38254025Global perspectives in hospitalized heart failure: regional and ethnic variation in patient characteristics, management, and outcomes
Q48218551Growth Hormone (GH) and Cardiovascular System
Q89601140Guideline-directed medical therapy in elderly patients with heart failure with reduced ejection fraction: a cohort study
Q90085905Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant
Q36424089Health Literacy Mediates the Relationship Between Age and Health Outcomes in Patients With Heart Failure
Q36079869Health Literacy and Heart Failure: A Systematic Review
Q47348712Health Literacy and Outcomes in Patients With Heart Failure: A Prospective Community Study
Q36141353Health literacy and mortality: a cohort study of patients hospitalized for acute heart failure
Q47922014Healthcare Costs Among Patients with Heart Failure: A Comparison of Costs between Matched Decedent and Survivor Cohorts
Q96026980Healthy lifestyle and risk of incident heart failure with preserved and reduced ejection fraction among post-menopausal women: The women's health initiative study
Q22241921Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association
Q30238784Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association
Q37065389Heart Failure Among Older Adults in Skilled Nursing Facilities: More of a Dilemma Than Many Now Realize.
Q38932260Heart Failure Incidence and Mortality in the Southern Community Cohort Study.
Q92715840Heart Failure With Preserved Ejection Fraction and Adipose Tissue: A Story of Two Tales
Q54963948Heart Failure and Frailty in the Community-Living Elderly Population: What the UFO Study Will Tell Us.
Q39540471Heart Failure in Older Adults
Q91600853Heart Failure in Older Adults: A Geriatrician Call for Action
Q26745543Heart Failure: Diagnosis, Management and Utilization
Q29547691Heart disease and stroke statistics--2014 update: a report from the American Heart Association
Q56210548Heart failure
Q26740285Heart failure across Asia: Same healthcare burden but differences in organization of care
Q93147758Heart failure awareness in the Korean general population: Results from the nationwide survey
Q92292783Heart failure drug treatment
Q93026435Heart failure hospitalization reduction and cost savings achieved by improved delivery of effective biventricular pacing: economic implications of the OLE study under the US setting
Q91755767Heart failure in Finland: clinical characteristics, mortality, and healthcare resource use
Q61454581Heart failure mortality compared between elderly and non-elderly Thai patients
Q92314987Heart failure mortality prediction using PRISM score and development of a classification and regression tree model to refer patients for palliative care consultation
Q38592514Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review
Q35578498Heart failure remote monitoring: evidence from the retrospective evaluation of a real-world remote monitoring program
Q91952587Heart failure risk reduction: is fit and overweight or obese better than unfit and normal weight?
Q38931738Heart failure with preserved ejection fraction and skeletal muscle physiology
Q43925452Heart failure, post-hospital mortality and renal function in Tanzania: A prospective cohort study
Q42199698Heart failure: preventing disease and death worldwide
Q41630624Heart rate-induced modifications of concentric left ventricular hypertrophy: exploration of a novel therapeutic concept
Q38654054Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics
Q92632420Heart-Type Fatty Acid-Binding Protein (H-FABP) and its Role as a Biomarker in Heart Failure: What Do We Know So Far?
Q33916984Heterogeneity in national U.S. mortality trends within heart disease subgroups, 2000-2015.
Q38664709High prevalence of subclinical cerebral infarction in patients with heart failure with preserved ejection fraction
Q41808626High risk percutaneous coronary interventions-significance of left ventricular assist device for clinical practice
Q40350551High-Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: MESA (Multi-Ethnic Study of Atherosclerosis).
Q52621433Home Hospitalization for Acute Decompensated Heart Failure: Opportunities and Strategies for Improved Health Outcomes.
Q34468845Home telehealth uptake and continued use among heart failure and chronic obstructive pulmonary disease patients: a systematic review
Q64131213Hospital-based quality improvement interventions for patients with heart failure: a systematic review
Q42354873How to establish a successful destination therapy ventricular assist device program
Q92454801Hurdles to Cardioprotection in the Critically Ill
Q35794539I Brazilian Registry of Heart Failure - Clinical Aspects, Care Quality and Hospitalization Outcomes
Q37676652Identification and Use of Frailty Indicators from Text to Examine Associations with Clinical Outcomes Among Patients with Heart Failure
Q36223832Identification of Emergency Department Patients With Acute Heart Failure at Low Risk for 30-Day Adverse Events: The STRATIFY Decision Tool
Q41232264If home telemonitoring reduces mortality in heart failure, is this just due to better guideline-based treatment?
Q38993415Imaging the Propagation of the Electromechanical Wave in Heart Failure Patients with Cardiac Resynchronization Therapy
Q92810672Immune Dysregulation in HFpEF: A Target for Mesenchymal Stem/Stromal Cell Therapy
Q39029380Immunosuppression and adult heart transplantation: emerging therapies and opportunities.
Q50083097Impact of Body Mass Index on Heart Failure by Race/Ethnicity From Get With The Guidelines-Heart Failure (GWTG-HF) Registry.
Q88711703Impact of Exercise Training on Peak Oxygen Uptake and its Determinants in Heart Failure with Preserved Ejection Fraction
Q36714012Impact of Nitrate Use on Survival in Acute Heart Failure: A Propensity-Matched Analysis
Q38667041Impact of Site Selection and Study Conduct on Outcomes in Global Clinical Trials
Q93377309Impact of a Pharmacist-Led Intervention on 30-Day Readmission and Assessment of Factors Predictive of Readmission in African American Men With Heart Failure
Q57574191Impact of a nurse-led home and clinic-based secondary prevention programme to prevent progressive cardiac dysfunction in high-risk individuals: the Nurse-led Intervention for Less Chronic Heart Failure (NIL-CHF) randomized controlled study
Q91646961Impact of leadership development workshops in facilitating team-based practice transformation
Q36805655Impaired skeletal muscle vasodilation during exercise in heart failure with preserved ejection fraction
Q47863918Implant Strategy-Specific Changes in Symptoms in Response to Left Ventricular Assist Devices.
Q38611533Implantable Hemodynamic Monitoring in Ambulatory Heart Failure: Who, When, Why, How?
Q52360900Implantable devices for heart failure monitoring and therapy.
Q55119320Implementation and Evaluation of a Smartphone-Based Telemonitoring Program for Patients With Heart Failure: Mixed-Methods Study Protocol.
Q99409927Improved 30 day heart failure rehospitalization prediction through the addition of device-measured parameters
Q38936829Improved Diastolic Function Is Associated With Higher Cardiac Output in Patients With Heart Failure Irrespective of Left Ventricular Ejection Fraction
Q46720750Improved medical expenditure and survival with integration of traditional Chinese medicine treatment in patients with heart failure: A nationwide population-based cohort study
Q46810238Improving care for patients with acute heart failure: before, during and after hospitalization
Q49911536Incident Heart Failure in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study.
Q58718917Indirect costs and public finance consequences of heart failure in Poland, 2012-2015
Q52589298Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.
Q57461747Inhibition of GSK-3 to induce cardiomyocyte proliferation-a recipe for in situ cardiac regeneration
Q90268226Inhibition of Interleukin-6/glycoprotein 130 signalling by Bazedoxifene ameliorates cardiac remodelling in pressure overload mice
Q52662712Innovation in Heart Failure Treatment: Life Expectancy, Disability, and Health Disparities.
Q38682105Inpatient Mortality Risk Scores and Postdischarge Events in Hospitalized Heart Failure Patients: A Community-Based Study
Q36868379Inpatient Utilization and Costs for Medicare Fee-for-Service Beneficiaries with Heart Failure
Q46539324Integrated Omic Analysis of a Guinea Pig Model of Heart Failure and Sudden Cardiac Death.
Q88151527Integrating electronic health records into the study of heart failure: promises and pitfalls
Q50069569Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Dec
Q45073053Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial).
Q48576464Intermittent Aortic Valve Opening and Risk of Thrombosis in Ventricular Assist Device Patients.
Q37257407International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry
Q89736017Intramyocardial Injections to De-Stiffen the Heart: A Subject-Specific in Silico Approach
Q47617357Invasive Validation of the Echocardiographic Assessment of Left Ventricular Filling Pressures Using the 2016 Diastolic Guidelines: Head-to-Head Comparison with the 2009 Guidelines.
Q26822876Iron deficiency in patients with heart failure
Q50048615Is ejection fraction in heart failure a limitation or an opportunity?
Q36012181It is time to stop counting calories, and time instead to promote dietary changes that substantially and rapidly reduce cardiovascular morbidity and mortality
Q39850479Knowledge Gaps in Cardiovascular Care of the Older Adult Population: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society
Q41686228Korean Guidelines for Diagnosis and Management of Chronic Heart Failure.
Q48581549LVAD Outflow Graft Angle and Thrombosis Risk.
Q38886473Large animal model of functional tricuspid regurgitation in pacing induced end-stage heart failure.
Q35353844Late systolic central hypertension as a predictor of incident heart failure: the Multi-ethnic Study of Atherosclerosis
Q88711503Left Ventricular Assist Devices in the Management of Heart Failure
Q89584259Left Ventricular Diastolic Myocardial Stiffness and End-Diastolic Myofibre Stress in Human Heart Failure Using Personalised Biomechanical Analysis
Q57288763Left ventricular assist device recovery: does duration of mechanical support matter?
Q90290987Left ventricular assist devices as destination therapy in stage D heart failure
Q40638466Left ventricular hypertrophy by ECG versus cardiac MRI as a predictor for heart failure.
Q46759837Less with More: Hospitalization Cost and Event Rates with Quadripolar versus Bipolar CRT-D System
Q93017682Long Noncoding Competing Endogenous RNA Networks in Age-Associated Cardiovascular Diseases
Q38599662Long-term survival following the development of heart failure in an elderly hypertensive population
Q38974968Longer-than-average length of stay in acute heart failure : Determinants and outcomes
Q55077284Low cardiorespiratory fitness is associated with higher extracellular vesicle counts in obese adults.
Q64085796Lower Hospitalization and Healthcare Costs With Sacubitril/Valsartan Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin-Receptor Blocker in a Retrospective Analysis of Patients With Heart Failure
Q41968841Lung Edema Clearance: Relevance to Patients with Lung Injury
Q94595715Macrophage Activities in Myocardial Infarction and Heart Failure
Q38537053Management of Noncardiac Comorbidities in Chronic Heart Failure
Q86767777Management of heart failure patients through integrative medical group visits
Q38402807Managing comorbidities in patients with chronic heart failure: first, do no harm
Q45063526Measures of Ventricular-Arterial Coupling and Incident Heart Failure With Preserved Ejection Fraction: A Matched Case-Control Analysis
Q89431912Mechanisms, diagnosis, and treatment of heart failure with preserved ejection fraction and diastolic dysfunction
Q40784558Medical resource use and expenditure in patients with chronic heart failure: a population-based analysis of 88 195 patients.
Q37076034Medication Adherence Interventions Improve Heart Failure Mortality and Readmission Rates: Systematic Review and Meta-Analysis of Controlled Trials
Q38738357Medication Adherence Mediates the Relationship Between Heart Failure Symptoms and Cardiac Event-Free Survival in Patients With Heart Failure
Q38351179Medication adherence interventions for heart failure patients: A meta-analysis.
Q38532867Medication management for left ventricular assist device thrombosis
Q41808958Medication regimen complexity in ambulatory older adults with heart failure
Q53540692Mediterranean diet and risk of heart failure: results from the PREDIMED randomized controlled trial.
Q42617697Mesenchymal stem cells for cardiac repair: are the actors ready for the clinical scenario?
Q90233412Metabolic and Vascular Effect of the Mediterranean Diet
Q51734232MiR-124 aggravates failing hearts by suppressing CD151-facilitated angiogenesis in heart.
Q26750638MicroRNA and Heart Failure
Q92832083Mid-regional pro-atrial natriuretic peptide for the early detection of non-acute heart failure
Q92530222Mineralocorticoid receptor antagonist use after hospitalization of patients with heart failure and post-discharge outcomes: a single-center retrospective cohort study
Q36877638Mitochondrial Reactive Oxygen Species Mediate Cardiac Structural, Functional, and Mitochondrial Consequences of Diet-Induced Metabolic Heart Disease
Q38246367Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart
Q92302079Modeling heart failure in animal models for novel drug discovery and development
Q30754539Mortality Among Patients Hospitalized With Heart Failure and Diabetes Mellitus: Results From the National Inpatient Sample 2000 to 2010.
Q58543913Moving into the next era of PET myocardial perfusion imaging: introduction of novel F-labeled tracers
Q37245084Moving toward comprehensive acute heart failure risk assessment in the emergency department: the importance of self-care and shared decision making
Q34559891Multidisciplinary group clinic appointments: the Self-Management and Care of Heart Failure (SMAC-HF) trial
Q49203906Murine Models of Heart Failure with Preserved Ejection Fraction: a "Fishing Expedition".
Q64051962Myocardial reconstruction in ischaemic cardiomyopathy
Q93186972Myocardial relaxation in human heart failure: Why sarcomere kinetics should be center-stage
Q41840019NIAMI: Towards the optimization of results in primary PCI.
Q64134434National Burden of Heart Failure Events in the United States, 2006 to 2014
Q46580571National Differences in Trends for Heart Failure Hospitalizations by Sex and Race/Ethnicity
Q47395561National Trends in Admission and In-Hospital Mortality of Patients With Heart Failure in the United States (2001-2014).
Q50905395Natriuretic Peptides in Older Patients With Heart Failure: A Look Into the Seeds of Time.
Q38780567Neprilysin inhibition with sacubitril/valsartan in the treatment of heart failure: mortality bang for your buck
Q98159528Neuromodulation Therapy in Heart Failure: Combined Use of Drugs and Devices
Q92960219New Mechanistic Insight and Approaches for the Field of Acute Mechanical Circulatory Support
Q39218629New developments in the pharmacotherapeutic management of heart failure in elderly patients: concerns and considerations
Q90057613New insights provided by myofibril mechanics in inherited cardiomyopathies
Q37722194New pharmacological and technological management strategies in heart failure
Q92485555Non-invasive Measurement of Dynamic Myocardial Stiffness Using Acoustic Radiation Force Impulse Imaging
Q35217259Non-invasive technology that improves cardiac function after experimental myocardial infarction: Whole Body Periodic Acceleration (pGz).
Q62610258Noninvasive Blood Pressure Monitor Designed for Patients With Heart Failure Supported with Continuous-Flow Left Ventricular Assist Devices
Q28075185Noninvasive Positive Pressure Ventilation in Chronic Heart Failure
Q50089990Normal findings on noninvasive cardiac assessment and the prediction of heart failure: The Multi-Ethnic Study of Atherosclerosis (MESA).
Q26741100Novel role of phosphodiesterase inhibitors in the management of end-stage heart failure
Q58083516Nuanxin capsule for heart failure: A systematic review of randomized controlled trials
Q92682304Nuclear receptor subfamily 4 group A member 2 inhibits activation of ERK signaling and cell growth in response to β-adrenergic stimulation in adult rat cardiomyocytes
Q35732491Nurse-Led Multidisciplinary Heart Failure Group Clinic Appointments: Methods, Materials, and Outcomes Used in the Clinical Trial
Q28085537Nutritional Interventions in Heart Failure: A Systematic Review of the Literature
Q49546408Observation Versus Inpatient Stay for Heart Failure: Is It Semantics?
Q90143267Opportunities and Challenges of Claims-Based Quality Assessment: The Case of Postdischarge β-Blocker Treatment in Patients With Heart Failure With Reduced Ejection Fraction
Q37670957Optimal timing of same-admission orthotopic heart transplantation after left ventricular assist device implantation
Q39142609Outcomes in acute heart failure: 30-day readmission versus death
Q90153276Outcomes of a Transitional Care Clinic to Reduce Heart Failure Readmissions at an Urban Academic Medical Center
Q90095054Outcomes of gastrointestinal bleeding in patients with left ventricular assist devices: a tertiary care experience
Q39027287Palliative Care Interventions for Patients with Heart Failure: A Systematic Review and Meta-Analysis
Q47549990Palliative Care in Heart Failure: Rationale, Evidence, and Future Priorities
Q37328775Parathyroid hormone and risk of heart failure in the general population: A meta-analysis of prospective studies
Q30823346Partial LVAD restores ventricular outputs and normalizes LV but not RV stress distributions in the acutely failing heart in silico.
Q38718829Pathophysiological mechanism and therapeutic role of S100 proteins in cardiac failure: a systematic review.
Q48095229Pathophysiology of acute heart failure syndrome: a knowledge gap.
Q38725363Patient Perceptions on Facilitating Follow-Up After Heart Failure Hospitalization.
Q39681115Patient engagement with a mobile web-based telemonitoring system for heart failure self-management: a pilot study.
Q90393579Patients report more severe daily limitations than recognized by their physicians
Q37693957Patients with heart failure as co-designers of an educational website: implications for medical education.
Q34115818Patients' annual income adequacy, insurance premiums and out-of-pocket expenses related to heart failure care.
Q36654892Patients' decision making process and expectations of a left ventricular assist device pre and post implantation
Q35028584Pediatric heart failure: current state and future possibilities
Q55411189Perceived Social Isolation and Outcomes in Patients With Heart Failure.
Q39264105Peripheral artery disease and risk of adverse outcomes in heart failure with preserved ejection fraction
Q35588902Perspectives from mechanical circulatory support coordinators on the pre-implantation decision process for destination therapy left ventricular assist devices
Q90449914Pharmacological and Non-pharmacological Strategies for Volume Overload in Acute Decompensated Congestive Heart Failure: A Review Article
Q47614022Pharmacotherapy Choice Is Associated with 2-Year Mortality for Patients with Heart Failure and Reduced Ejection Fraction
Q40027666Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
Q91988023Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure
Q90666819Physical Function, Frailty, Cognition, Depression, and Quality of Life in Hospitalized Adults ≥60 Years With Acute Decompensated Heart Failure With Preserved Versus Reduced Ejection Fraction
Q40311889Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure
Q30730318Post-discharge Follow-up Characteristics Associated With 30-Day Readmission After Heart Failure Hospitalization
Q38847918Potential beneficial effects of sacubitril-valsartan in renal disease: a new field for a new drug
Q30251531Potential new drug treatments for congestive heart failure
Q38908723Practical approach on frail older patients attended for acute heart failure
Q90111024Precipitating Factors for Hospitalization with Heart Failure: Prevalence and Clinical Impact Observations from the Gulf CARE (Gulf aCute heArt failuRe rEgistry)
Q36992652Predicting Heart Failure With Preserved and Reduced Ejection Fraction: The International Collaboration on Heart Failure Subtypes
Q91071243Predicting adults likely to develop heart failure using readily available clinical information: An analysis of heart failure incidence using the NHEFS
Q92425904Prediction of Left Ventricular Mechanics Using Machine Learning
Q91105604Prediction of incident heart failure by serum amino-terminal pro-B-type natriuretic peptide level in a community-based cohort
Q35855340Predictors of medication nonadherence differ among black and white patients with heart failure
Q47738696Preload-corrected dynamic Starling mechanism in patients with heart failure with preserved ejection fraction.
Q48524715Presence of micro- and macroalbuminuria and the association with cardiac mechanics in patients with type 2 diabetes.
Q40066805Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality
Q39172352Primary palliative care for heart failure: what is it? How do we implement it?
Q92628957Problems Experienced in the First Month After Discharge From a Heart Failure-Related Hospitalization
Q61797746Proceedings of the 3rd annual Acute Cardiac Unloading and REcovery (A-CURE) symposium
Q47797992Production of Single Contracting Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Matrigel Mattress Technique.
Q30241494Productivity losses associated with cardiovascular disease: a systematic review
Q90219822Prognostic Impact of Chronic Kidney Disease in Patients with Heart Failure
Q36309695Prognostic Impact of In-Hospital and Postdischarge Heart Failure in Patients With Acute Myocardial Infarction: A Nationwide Analysis Using Data From the Cardiovascular Disease in Norway (CVDNOR) Project
Q40272769Prognostic value of long-term blood pressure changes in patients with chronic heart failure
Q40052538Prospective Association of Physical Activity and Heart Failure Hospitalizations Among Black Adults With Normal Ejection Fraction: The Jackson Heart Study.
Q39195639Protective Actions of H2S in Acute Myocardial Infarction and Heart Failure
Q39432092Protein kinase C and cardiac dysfunction: a review
Q38268959Proteomics of the periconception milieu
Q89712807Pseudouridine and N-formylmethionine associate with left ventricular mass index: Metabolome-wide association analysis of cardiac remodeling
Q40490176Psychiatric conditions as predictors of rehospitalization among African American patients hospitalized with heart failure
Q55119532Psychometric Analysis of the Heart Failure Somatic Perception Scale as a Measure of Patient Symptom Perception.
Q87939322Pulmonary Congestion by Lung Ultrasound in Ambulatory Patients With Heart Failure With Reduced or Preserved Ejection Fraction and Hypertension
Q30851193Pulmonary artery pressure-guided heart failure management: US cost-effectiveness analyses using the results of the CHAMPION clinical trial
Q89450884Race and Sex Differences in Modifiable Risk Factors and Incident Heart Failure
Q38787755Race/Ethnic Differences in Outcomes Among Hospitalized Medicare Patients With Heart Failure and Preserved Ejection Fraction
Q39617982Racial and Ethnic Differences in Heart Failure Readmissions and Mortality in a Large Municipal Healthcare System.
Q47250954Racial and Ethnic Differences in Trajectories of Hospitalization in US Men and Women With Heart Failure
Q36085697Racial differences in clinical treatment and self-care behaviors of adults with chronic heart failure
Q91860801Rapamycin persistently improves cardiac function in aged, male and female mice, even following cessation of treatment
Q49848555Rationale and design of TRANSITION: a randomized trial of pre-discharge vs. post-discharge initiation of sacubitril/valsartan.
Q39626663Rationale and design of the PREFERS (Preserved and Reduced Ejection Fraction Epidemiological Regional Study) Stockholm heart failure study: an epidemiological regional study in Stockholm county of 2.1 million inhabitants
Q38261513Rationale and therapeutic opportunities for natriuretic peptide system augmentation in heart failure
Q39410727Rationales and choices for the treatment of patients with NYHA class II heart failure
Q36098094Reactive hyperemia is associated with adverse clinical outcomes in heart failure
Q35849384Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure
Q36290215Real world heart failure epidemiology and outcome: A population-based analysis of 88,195 patients.
Q46335976Recent advances in point-of-care testing for natriuretic peptides: potential impact on heart failure diagnosis and management
Q99565745Redox signaling and Alzheimer's disease: from pathomechanism insights to biomarker discovery and therapy strategy
Q37011796Reducing Disparities in Cardiovascular Health: Social Determinants Matter
Q38192824Regenerative implants for cardiovascular tissue engineering
Q37710165Registry-Based Pragmatic Trials in Heart Failure: Current Experience and Future Directions
Q48369499Regulation of circulating chromogranin B levels in heart failure.
Q50355346Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial: Design and rationale.
Q63811744Relation Between Cigarette Smoking and Heart Failure (from the Multiethnic Study of Atherosclerosis)
Q93157384Relation of Living in a "Food Desert" to Recurrent Hospitalizations in Patients With Heart Failure
Q97567792Relationship between the place of living and mortality in patients with advanced heart failure
Q58790933Relationship of Electromechanical Dyssynchrony in Patients Submitted to CRT With LV Lead Implantation Guided by Gated Myocardial Perfusion Spect
Q41069120Relationship of Office and Ambulatory Blood Pressure With Left Ventricular Global Longitudinal Strain
Q58705696Relationship of Transmural Variations in Myofiber Contractility to Left Ventricular Ejection Fraction: Implications for Modeling Heart Failure Phenotype With Preserved Ejection Fraction
Q38744470Remote Monitoring in Heart Failure: the Current State
Q38953625Remote Monitoring to Reduce Heart Failure Readmissions
Q39383368Remote haemodynamic-guided care for patients with chronic heart failure: a meta-analysis of completed trials
Q55484690Resource Utilization in Pediatric Patients Supported With Ventricular Assist Devices in the United States: A Multicenter Study From the Pediatric Interagency Registry for Mechanically Assisted Circulatory Support and the Pediatric Health Information
Q64245682Responsiveness and minimal clinically important difference of the Minnesota living with heart failure questionnaire
Q59792533Risk Stratification of Sudden Cardiac Death in Patients with Heart Failure: An update
Q57054183Role of Percutaneous Chronic Total Occlusion Interventions in Patients with Ischemic Cardiomyopathy and Reduced Left Ventricular Ejection Fraction
Q39458524Role of Speckle Tracking Echocardiography in Dilated Cardiomyopathy: A Review
Q39148915Role of the Pharmacist for Improving Self-care and Outcomes in Heart Failure
Q90676214SGLT-2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects
Q95570983SGLT-2 inhibitors for people with type 2 diabetes
Q41810657STOP-HF: Expanding the role of HF programs into the community
Q90583568Sacubitril/Valsartan (LCZ696): A Novel Treatment for Heart Failure and its Estimated Cost Effectiveness, Budget Impact, and Disease Burden Reduction in Germany
Q62491883Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram
Q48033305Seasonal variation in hospitalization outcomes in patients admitted for heart failure in the United States.
Q45862456Selective Pressure-Regulated Retroinfusion for Gene Therapy Application in Ischemic Heart Disease
Q58610626Self-Care Interventions for Adults with Heart Failure: A Systematic Review and Meta-analysis Protocol
Q91616835Self-management of heart failure in dementia and cognitive impairment: a systematic review
Q38798476Serelaxin for the treatment of heart failure
Q33845755Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study
Q33970136Serelaxin: a novel therapy for acute heart failure with a range of hemodynamic and non-hemodynamic actions
Q89535686Serial Biomarkers of De Novo Lipogenesis Fatty Acids and Incident Heart Failure in Older Adults: The Cardiovascular Health Study
Q36248209Severity of Remodeling, Myocardial Viability, and Survival in Ischemic LV Dysfunction After Surgical Revascularization.
Q38635685Sex-specific temporal trends in the incidence and prevalence of hospitalized patients with preserved versus reduced left ventricular ejection fraction heart failure: A Japanese community-wide study
Q55088794Shexiang Baoxin Pills as an Adjuvant Treatment for Chronic Heart Failure: A System Review and Meta-Analysis.
Q38863043Skilled Nursing Facility Use and Hospitalizations in Heart Failure: A Community Linkage Study
Q38636431Sleep disordered breathing in older adults with heart failure with preserved ejection fraction
Q38546917Small molecule and peptide therapies for chronic heart failure: a patent review (2011 - 2014).
Q37708944Soluble tumor necrosis factor receptors and heart failure risk in older adults: Health, Aging, and Body Composition (Health ABC) Study
Q28070064Spotlight on valsartan-sacubitril fixed-dose combination for heart failure: the evidence to date
Q88673406Stable but Progressive Nature of Heart Failure: Considerations for Primary Care Physicians
Q35690546Stage A Heart Failure Is Not Adequately Recognized in US Adults: Analysis of the National Health and Nutrition Examination Surveys, 2007-2010
Q98466834Statistics of heart failure and mechanical circulatory support in 2020
Q47872194Strategies for supporting intervention fidelity in the rehabilitation therapy in older acute heart failure patients (REHAB-HF) trial
Q35335685Stratifying patients at the risk of heart failure hospitalization using existing device diagnostic thresholds
Q88298129Stress, cognitive appraisal, coping, and event free survival in patients with heart failure
Q24186286Structured telephone support or non-invasive telemonitoring for patients with heart failure
Q58732357Study protocol for a cohort study of patients with advanced heart failure in Singapore
Q92303973Study protocol of coaching end-of-life palliative care for advanced heart failure patients and their family caregivers in rural appalachia: a randomized controlled trial
Q64927166Subcutaneous Furosemide in Heart Failure: Pharmacokinetic Characteristics of a Newly Buffered Solution.
Q99629087Substrate metabolism regulated by Sestrin2-mTORC1 alleviates pressure overload-induced cardiac hypertrophy in aged heart
Q89235554Substrates and potential therapeutics of ventricular arrhythmias in heart failure
Q47215949Suppression of Activated FOXO Transcription Factors in the Heart Prolongs Survival in a Mouse Model of Laminopathies
Q38945834Symptom burden in heart failure: assessment, impact on outcomes, and management.
Q91996002Taking a Day Off in the Care of Patients With Acute Decompensated Heart Failure: The Weekend Effect
Q52685524Taking cardiology clinical trials to the next level: A call to action.
Q37425473Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial
Q38223913Telemonitoring in heart failure: Big Brother watching over you.
Q37619070Temporal Trends of Hospitalized Patients with Heart Failure in Korea
Q94554274Tetranectin, a potential novel diagnostic biomarker of heart failure, is expressed within the myocardium and associates with cardiac fibrosis
Q57818797The American Heart Association Heart Failure Summit, Bethesda, April 12, 2017
Q56744993The CardioMEMS system in the clinical management of end-stage heart failure patients: three case reports
Q55265979The Cost of Hyperkalemia in the United States.
Q52684873The Current Focus of Heart Failure Clinical Trials.
Q47787428The Development and Acceptability of a Mobile Application for Tracking Symptoms of Heart Failure Among Older Adults
Q36422577The Frank-Starling mechanism involves deceleration of cross-bridge kinetics and is preserved in failing human right ventricular myocardium
Q89990345The Heart Failure Association Atlas: rationale, objectives, and methods
Q52715902The Impact of Pazopanib on the Cardiovascular System.
Q28067832The Role of Cardiac Side Population Cells in Cardiac Regeneration
Q36079293The Role of Hypertension in Race-Ethnic Disparities in Cardiovascular Disease
Q88711740The Role of Ivabradine and Trimetazidine in the New ESC HF Guidelines
Q52679961The State of the Science on Integrating Palliative Care in Heart Failure.
Q38798221The Third Time's a Charm: Psychometric Testing and Update of the Atlanta Heart Failure Knowledge Test
Q38558614The Three-Decade Long Journey in Heart Failure Drug Development
Q30240091The association of serum magnesium and mortality outcomes in heart failure patients: A systematic review and meta-analysis
Q90329480The burden of heart failure in the general population: a clearer and more concerning picture
Q26766151The cardiac enigma: current conundrums in heart failure research
Q98170060The conventional isoproterenol-induced heart failure model does not consistently mimic the diaphragmatic dysfunction observed in patients
Q60302039The cost impact to Medicare of shifting treatment of worsening heart failure from inpatient to outpatient management settings
Q37306238The current and future financial burden of hospital admissions for heart failure in Canada: a cost analysis
Q92271500The economic burden of heart failure in Denmark from 1998 to 2016
Q58804792The economic case for US hospitals to revise their approach to heart failure readmission reduction
Q38611592The economic impact of patients with heart failure on the Lebanese healthcare system.
Q51731338The effect of nurse-led group discussions by race on depressive symptoms in patients with heart failure.
Q42340578The evolution of left ventricular assist devices-a moment to reflect
Q58115629The expanding role of implantable devices to monitor heart failure and pulmonary hypertension
Q38343935The genetic landscape of cardiomyopathy and its role in heart failure.
Q55078568The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions.
Q38654636The impact of medication nonadherence on the relationship between mortality risk and depression in heart failure
Q47791214The ixCELL-DCM Trial: Rationale and Design
Q43153470The life cycle of the heart failure patient
Q59335403The metabolic model of heart failure: the role of sodium glucose co-transporter-2 (SGLT-2) inhibition
Q38742939The oxoglutarate receptor 1 (OXGR1) modulates pressure overload-induced cardiac hypertrophy in mice.
Q38222648The pathophysiology of heart failure with preserved ejection fraction.
Q47192599The prognostic significance of improvement in exercise capacity in heart failure patients who participate in cardiac rehabilitation programme
Q26795502The renal nerves in chronic heart failure: efferent and afferent mechanisms
Q49488565Therapeutic Targets for the Multi-system Pathophysiology of Heart Failure: Exercise Training.
Q89483519Therapeutic options in advanced heart failure
Q104137178Time-sensitive approach in the management of acute heart failure
Q64012586Tissue repair and regeneration with endogenous stem cells
Q36144376Tracking clinical status for heart failure patients using ballistocardiography and electrocardiography signal features
Q38799792Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network).
Q64092741Transcriptomics of cardiac biopsies reveals differences in patients with or without diagnostic parameters for heart failure with preserved ejection fraction
Q36101517Transition Networks in a Cohort of Patients with Congestive Heart Failure: A Novel Application of Informatics Methods to Inform Care Coordination.
Q47155338Trauma Resuscitation in a Left Ventricular Assist Device Patient: An Emergency Medicine Simulation Scenario
Q38821193Treatment Considerations and the Role of the Clinical Pharmacist Throughout Transitions of Care for Patients With Acute Heart Failure
Q38145265Treatment of acute heart failure in the emergency department
Q51412130Trends in Hospitalizations and Survival of Acute Decompensated Heart Failure in Four US Communities (2005-2014): The Atherosclerosis Risk in Communities (ARIC) Study Community Surveillance.
Q64111459Trends in Readmissions and Length of Stay for Patients Hospitalized With Heart Failure in Canada and the United States
Q38813931Trends in health care expenditure among US adults with heart failure: The Medical Expenditure Panel Survey 2002-2011.
Q92521896Trends in the Use of Cardiac Imaging for Patients With Heart Failure in Canada
Q38823420Trends in the risk of early and late-onset heart failure as an adverse outcome of acute myocardial infarction: A Cardiovascular Disease in Norway project
Q34695096Trial of a family-based education program for heart failure patients in rural Thailand
Q38802222Turning Failure into Success: Trials of the Heart Failure Clinical Research Network
Q90678493US trends in premature heart disease mortality over the past 50 years: Where do we go from here?
Q41875333Ultra-Sensitive NT-proBNP Quantification for Early Detection of Risk Factors Leading to Heart Failure.
Q38795329Ultrafiltration Therapy for Heart Failure: Balancing Likely Benefits against Possible Risks
Q26996486Understanding the epidemic of heart failure: past, present, and future
Q38732367Unlocking the box: basic requirements for an ideal ventricular assist device controller
Q49892870Updates on Device-Based Therapies for Patients with Heart Failure.
Q38833346Use of Tumor Necrosis Factor Alpha Inhibitors for Inflammatory Bowel Disease Patients with Concurrent Heart Failure
Q94503116Utilization of Ultrasound to Assess Volume Status in Heart Failure
Q89591952Validating patient prioritization in the 2018 Revised United Network for Organ Sharing Heart Allocation System: A single-center experience
Q92158706Validity and Reliability Evaluation of the Persian Version of the Heart Failure-Specific Health Literacy Scale
Q64271605Ventricular Assist Devices: an Evolving Field
Q58759402Vital Signs: State-Level Variation in Nonfatal and Fatal Cardiovascular Events Targeted for Prevention by Million Hearts 2022
Q47169224Vitamin D3 repletion versus placebo as adjunctive treatment of heart failure patient quality of life and hormonal indices: a randomized, double-blind, placebo-controlled trial.
Q100490880Waist-to-height ratio and skipping breakfast are predictive factors for high blood pressure in adolescents
Q38950580What is the cost of non-response to cardiac resynchronization therapy? Hospitalizations and healthcare utilization in the CRT-D population
Q38116756What is the optimal place for heart failure treatment and care: home or hospital?
Q33944629What puts heart failure patients at risk for poor medication adherence?
Q58795766Whey protein supplementation for the preservation of mass and muscular strength of patients with heart failure: study protocol for a randomized controlled trial
Q64902607Zhenwu decoction for chronic heart failure: Protocol for a systematic review and meta-analysis.
Q52678651[Efficacy of a multidisciplinary care management program for patients admitted at hospital because of heart failure (ProMIC)].

Search more.